High-dose antioxidants for central serous chorioretinopathy; the randomized placebo-controlled study.
about
Interventions for central serous chorioretinopathy: a network meta-analysisTopical nepafenac in treatment of acute central serous chorioretinopathy.Diagnosed a Patient with Central Serous Chorioretinopathy? Now What?: Management of Central Serous Chorioretinopathy.Serum dehydroepiandrosterone sulphate, total antioxidant capacity, and total oxidant status in central serous chorioretinopathy.A novel marker in acute central serous chorioretinopathy: thiol/disulfide homeostasis.
P2860
High-dose antioxidants for central serous chorioretinopathy; the randomized placebo-controlled study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
High-dose antioxidants for cen ...... ized placebo-controlled study.
@ast
High-dose antioxidants for cen ...... ized placebo-controlled study.
@en
High-dose antioxidants for cen ...... ized placebo-controlled study.
@nl
type
label
High-dose antioxidants for cen ...... ized placebo-controlled study.
@ast
High-dose antioxidants for cen ...... ized placebo-controlled study.
@en
High-dose antioxidants for cen ...... ized placebo-controlled study.
@nl
prefLabel
High-dose antioxidants for cen ...... ized placebo-controlled study.
@ast
High-dose antioxidants for cen ...... ized placebo-controlled study.
@en
High-dose antioxidants for cen ...... ized placebo-controlled study.
@nl
P2093
P2860
P356
P1433
P1476
High-dose antioxidants for cen ...... ized placebo-controlled study.
@en
P2093
Mansing Ratanasukon
Patama Bhurayanontachai
Pichai Jirarattanasopa
P2860
P2888
P356
10.1186/1471-2415-12-20
P577
2012-07-16T00:00:00Z
P5875
P6179
1011925438